+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Next-Generation Sequencing Data Analysis Market by Workflow , by Product Type , by Sourcing Type , by Read Length , and by Region -

  • PDF Icon

    Report

  • 250 Pages
  • November 2022
  • Region: Global
  • Transparency Market Research
  • ID: 5710022

Next-Generation Sequencing Data Analysis Market - Scope of Report

This report on the global Next-generation sequencing data analysis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global Next-generation sequencing data analysis market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Next-generation sequencing data analysis market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Next-generation sequencing data analysis market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Next-generation sequencing data analysis market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global Next-generation sequencing data analysis market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Next-generation sequencing data analysis market.

The report delves into the competitive landscape of the global Next-generation sequencing data analysis market. Key players operating in the global Next-generation sequencing data analysis market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global Next-generation sequencing data analysis market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market Next-generation sequencing data analysis.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:

  • WorldWideScience.org
  • Elsevier, Inc
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service
  • Trade Data Sources
  • Trade Map
  • UN Comtrade
  • Trade Atlas
  • Company Information
  • OneSource Business Browser
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

The publisher conducts primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd
  • IBA Worldwide
  • Mevion Medical Systems, Inc
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with the publisher's “Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others

Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Investment Feasibility Matrix
3.4. Value Chain Analysis
3.4.1. Profit Margin Analysis
3.4.2. Wholesalers and Distributors
3.4.3. Retailers
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
4. Global Next-Generation Sequencing Data Analysis Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Next-Generation Sequencing Data Analysis Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
5.3.1. NGS Commercial Software
5.3.2. Services
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
6. Global Next-Generation Sequencing Data Analysis Market Analysis 2017-2021 and Forecast 2022-2032, By Workflow
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Workflow , 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Workflow , 2022-2032
6.3.1. Secondary
6.3.2. Tertiary
6.3.3. Primary
6.4. Y-o-Y Growth Trend Analysis By Workflow , 2017-2021
6.5. Absolute $ Opportunity Analysis By Workflow , 2022-2032
7. Global Next-Generation Sequencing Data Analysis Market Analysis 2017-2021 and Forecast 2022-2032, By Sourcing Type
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Sourcing Type, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Sourcing Type, 2022-2032
7.3.1. Outsourced
7.3.2. In-house
7.4. Y-o-Y Growth Trend Analysis By Sourcing Type, 2017-2021
7.5. Absolute $ Opportunity Analysis By Sourcing Type, 2022-2032
8. Global Next-Generation Sequencing Data Analysis Market Analysis 2017-2021 and Forecast 2022-2032, By Read Length
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) Analysis By Read Length, 2017-2021
8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Read Length, 2022-2032
8.3.1. Long Read Sequencing
8.3.2. Short Read Sequencing
8.3.3. Very Long Read Sequencing
8.4. Y-o-Y Growth Trend Analysis By Read Length, 2017-2021
8.5. Absolute $ Opportunity Analysis By Read Length, 2022-2032
9. Global Next-Generation Sequencing Data Analysis Market Analysis 2017-2021 and Forecast 2022-2032, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia
9.3.6. Oceania
9.3.7. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Next-Generation Sequencing Data Analysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. By Product Type
10.2.3. By Workflow
10.2.4. By Sourcing Type
10.2.5. By Read Length
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Workflow
10.3.4. By Sourcing Type
10.3.5. By Read Length
10.4. Key Takeaways
11. Latin America Next-Generation Sequencing Data Analysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Argentina
11.2.1.4. Rest of Latin America
11.2.2. By Product Type
11.2.3. By Workflow
11.2.4. By Sourcing Type
11.2.5. By Read Length
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Workflow
11.3.4. By Sourcing Type
11.3.5. By Read Length
11.4. Key Takeaways
12. Europe Next-Generation Sequencing Data Analysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. Italy
12.2.1.3. France
12.2.1.4. U.K.
12.2.1.5. Spain
12.2.1.6. Russia
12.2.1.7. BENELUX
12.2.1.8. Rest of Europe
12.2.2. By Product Type
12.2.3. By Workflow
12.2.4. By Sourcing Type
12.2.5. By Read Length
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Workflow
12.3.4. By Sourcing Type
12.3.5. By Read Length
12.4. Key Takeaways
13. East Asia Next-Generation Sequencing Data Analysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product Type
13.2.3. By Workflow
13.2.4. By Sourcing Type
13.2.5. By Read Length
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Workflow
13.3.4. By Sourcing Type
13.3.5. By Read Length
13.4. Key Takeaways
14. South Asia Next-Generation Sequencing Data Analysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. India
14.2.1.2. Thailand
14.2.1.3. Malaysia
14.2.1.4. Indonesia
14.2.1.5. Rest of South Asia
14.2.2. By Product Type
14.2.3. By Workflow
14.2.4. By Sourcing Type
14.2.5. By Read Length
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Workflow
14.3.4. By Sourcing Type
14.3.5. By Read Length
14.4. Key Takeaways
15. Oceania Next-Generation Sequencing Data Analysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. Australia
15.2.1.2. New Zealand
15.2.2. By Product Type
15.2.3. By Workflow
15.2.4. By Sourcing Type
15.2.5. By Read Length
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Workflow
15.3.4. By Sourcing Type
15.3.5. By Read Length
15.4. Key Takeaways
16. MEA Next-Generation Sequencing Data Analysis Market Analysis 2017-2021 and Forecast 2022-2032, By Country
16.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
16.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
16.2.1. By Country
16.2.1.1. GCC
16.2.1.2. Rest of MEA
16.2.2. By Product Type
16.2.3. By Workflow
16.2.4. By Sourcing Type
16.2.5. By Read Length
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product Type
16.3.3. By Workflow
16.3.4. By Sourcing Type
16.3.5. By Read Length
16.4. Key Takeaways
17. Key Countries Next-Generation Sequencing Data Analysis Market Analysis
17.1. U.S.
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2021
17.1.2.1. By Product Type
17.1.2.2. By Workflow
17.1.2.3. By Sourcing Type
17.1.2.4. By Read Length
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2021
17.2.2.1. By Product Type
17.2.2.2. By Workflow
17.2.2.3. By Sourcing Type
17.2.2.4. By Read Length
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2021
17.3.2.1. By Product Type
17.3.2.2. By Workflow
17.3.2.3. By Sourcing Type
17.3.2.4. By Read Length
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2021
17.4.2.1. By Product Type
17.4.2.2. By Workflow
17.4.2.3. By Sourcing Type
17.4.2.4. By Read Length
17.5. Argentina
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2021
17.5.2.1. By Product Type
17.5.2.2. By Workflow
17.5.2.3. By Sourcing Type
17.5.2.4. By Read Length
17.6. Germany
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2021
17.6.2.1. By Product Type
17.6.2.2. By Workflow
17.6.2.3. By Sourcing Type
17.6.2.4. By Read Length
17.7. Italy
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2021
17.7.2.1. By Product Type
17.7.2.2. By Workflow
17.7.2.3. By Sourcing Type
17.7.2.4. By Read Length
17.8. France
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2021
17.8.2.1. By Product Type
17.8.2.2. By Workflow
17.8.2.3. By Sourcing Type
17.8.2.4. By Read Length
17.9. U.K.
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2021
17.9.2.1. By Product Type
17.9.2.2. By Workflow
17.9.2.3. By Sourcing Type
17.9.2.4. By Read Length
17.10. Spain
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2021
17.10.2.1. By Product Type
17.10.2.2. By Workflow
17.10.2.3. By Sourcing Type
17.10.2.4. By Read Length
17.11. Russia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2021
17.11.2.1. By Product Type
17.11.2.2. By Workflow
17.11.2.3. By Sourcing Type
17.11.2.4. By Read Length
17.12. BENELUX
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2021
17.12.2.1. By Product Type
17.12.2.2. By Workflow
17.12.2.3. By Sourcing Type
17.12.2.4. By Read Length
17.13. China
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2021
17.13.2.1. By Product Type
17.13.2.2. By Workflow
17.13.2.3. By Sourcing Type
17.13.2.4. By Read Length
17.14. Japan
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2021
17.14.2.1. By Product Type
17.14.2.2. By Workflow
17.14.2.3. By Sourcing Type
17.14.2.4. By Read Length
17.15. South Korea
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2021
17.15.2.1. By Product Type
17.15.2.2. By Workflow
17.15.2.3. By Sourcing Type
17.15.2.4. By Read Length
17.16. India
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2021
17.16.2.1. By Product Type
17.16.2.2. By Workflow
17.16.2.3. By Sourcing Type
17.16.2.4. By Read Length
17.17. Thailand
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2021
17.17.2.1. By Product Type
17.17.2.2. By Workflow
17.17.2.3. By Sourcing Type
17.17.2.4. By Read Length
17.18. Malaysia
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2021
17.18.2.1. By Product Type
17.18.2.2. By Workflow
17.18.2.3. By Sourcing Type
17.18.2.4. By Read Length
17.19. Indonesia
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2021
17.19.2.1. By Product Type
17.19.2.2. By Workflow
17.19.2.3. By Sourcing Type
17.19.2.4. By Read Length
17.20. Australia
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2021
17.20.2.1. By Product Type
17.20.2.2. By Workflow
17.20.2.3. By Sourcing Type
17.20.2.4. By Read Length
17.21. New Zealand
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2021
17.21.2.1. By Product Type
17.21.2.2. By Workflow
17.21.2.3. By Sourcing Type
17.21.2.4. By Read Length
17.22. GCC Countries
17.22.1. Pricing Analysis
17.22.2. Market Share Analysis, 2021
17.22.2.1. By Product Type
17.22.2.2. By Workflow
17.22.2.3. By Sourcing Type
17.22.2.4. By Read Length
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Product Type
18.3.3. By Workflow
18.3.4. By Sourcing Type
18.3.5. By Read Length
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Thermo Fisher Scientific
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.1.5.2. Product Strategy
19.1.1.5.3. Channel Strategy
19.1.2. Qiagen
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.2.5.2. Product Strategy
19.1.2.5.3. Channel Strategy
19.1.3. Illumina
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.3.5.2. Product Strategy
19.1.3.5.3. Channel Strategy
19.1.4. F. Hoffmann-La Roche Ltd
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.4.5.2. Product Strategy
19.1.4.5.3. Channel Strategy
19.1.5. Agilent Technologies
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.5.5.2. Product Strategy
19.1.5.5.3. Channel Strategy
19.1.6. Genuity Science
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.6.5.2. Product Strategy
19.1.6.5.3. Channel Strategy
19.1.7. Fabric Genomics, Inc.
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.7.5.2. Product Strategy
19.1.7.5.3. Channel Strategy
19.1.8. Bio-Rad Laboratories, Inc.
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.8.5.2. Product Strategy
19.1.8.5.3. Channel Strategy
19.1.9. PierianDx
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.9.5.2. Product Strategy
19.1.9.5.3. Channel Strategy
19.1.10. Precigen Bioinformatics Germany GmbH
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.10.5.2. Product Strategy
19.1.10.5.3. Channel Strategy
19.1.11. Partek Incorporated
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.11.5.2. Product Strategy
19.1.11.5.3. Channel Strategy
19.1.12. Eurofins Scientific
19.1.12.1. Overview
19.1.12.2. Product Portfolio
19.1.12.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.12.4. Sales Footprint
19.1.12.5. Strategy Overview
19.1.12.5.1. Marketing Strategy
19.1.12.5.2. Product Strategy
19.1.12.5.3. Channel Strategy
19.1.13. Pacific Biosciences of California, Inc.
19.1.13.1. Overview
19.1.13.2. Product Portfolio
19.1.13.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.13.4. Sales Footprint
19.1.13.5. Strategy Overview
19.1.13.5.1. Marketing Strategy
19.1.13.5.2. Product Strategy
19.1.13.5.3. Channel Strategy
19.1.14. DNASTAR, Inc.
19.1.14.1. Overview
19.1.14.2. Product Portfolio
19.1.14.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.14.4. Sales Footprint
19.1.14.5. Strategy Overview
19.1.14.5.1. Marketing Strategy
19.1.14.5.2. Product Strategy
19.1.14.5.3. Channel Strategy
19.1.15. Congenica Ltd.
19.1.15.1. Overview
19.1.15.2. Product Portfolio
19.1.15.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.15.4. Sales Footprint
19.1.15.5. Strategy Overview
19.1.15.5.1. Marketing Strategy
19.1.15.5.2. Product Strategy
19.1.15.5.3. Channel Strategy
19.1.16. Fabric Genomics, Inc.
19.1.16.1. Overview
19.1.16.2. Product Portfolio
19.1.16.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.16.4. Sales Footprint
19.1.16.5. Strategy Overview
19.1.16.5.1. Marketing Strategy
19.1.16.5.2. Product Strategy
19.1.16.5.3. Channel Strategy
19.1.17. Genuity Science
19.1.17.1. Overview
19.1.17.2. Product Portfolio
19.1.17.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.17.4. Sales Footprint
19.1.17.5. Strategy Overview
19.1.17.5.1. Marketing Strategy
19.1.17.5.2. Product Strategy
19.1.17.5.3. Channel Strategy
19.1.18. DNAnexus Inc.
19.1.18.1. Overview
19.1.18.2. Product Portfolio
19.1.18.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.18.4. Sales Footprint
19.1.18.5. Strategy Overview
19.1.18.5.1. Marketing Strategy
19.1.18.5.2. Product Strategy
19.1.18.5.3. Channel Strategy
19.1.19. SciGenom Labs Pvt. Ltd.
19.1.19.1. Overview
19.1.19.2. Product Portfolio
19.1.19.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.19.4. Sales Footprint
19.1.19.5. Strategy Overview
19.1.19.5.1. Marketing Strategy
19.1.19.5.2. Product Strategy
19.1.19.5.3. Channel Strategy
19.1.20. Golden Helix, Inc.
19.1.20.1. Overview
19.1.20.2. Product Portfolio
19.1.20.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
19.1.20.4. Sales Footprint
19.1.20.5. Strategy Overview
19.1.20.5.1. Marketing Strategy
19.1.20.5.2. Product Strategy
19.1.20.5.3. Channel Strategy
20. Assumptions & Acronyms Used21. Research Methodology

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Thermo Fisher Scientific
  • Qiagen
  • Illumina
  • F. Hoffmann-La Roche Ltd
  • Agilent Technologies
  • Genuity Science
  • Fabric Genomics, Inc.